PR Hub

San Diego And Tokyo

Ambit Biosciences and Astellas Announce Upcoming Presentation of AC220 Data at the 16th Annual Congress of the European Hematology Association


SAN DIEGO and TOKYO, June 9, 2011 - Ambit Biosciences Corporation and Astellas Pharma Inc.
MORE..

Ambit to Receive a US$40 Million Upfront Cash Payment; Up to US$350 Million in Pre-Commercialization Milestones, Double-Digit Royalties with Option to Co-promote and Share Profits in U.S.


SAN DIEGO and TOKYO, December 18 - Ambit Biosciences Corporation and Astellas Pharma Inc.
MORE..
Older News
S M T W T F S
22 23 24 25 26 27 28
29 30 31 1 2 3 4
5 6 7 8 9 10 11
Copyright© 2011 The Gaea Times